Abbott Laboratories (ABT) Revenue — Quarter Ended Sep 30, 2025
Revenue increased in the current quarter. The growth rate was stronger compared to the same quarter last year but slower than the immediately preceding quarter.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue increased in the current quarter. The growth rate was stronger compared to the same quarter last year but slower than the immediately preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.4B
Revenue reported for this quarter.
Quarter-over-quarter
+2.0%
Change from the immediately preceding quarter.
Year-over-year
+6.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$43.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $11B | +7.2% |
| Mar 31, 2025 | $10.4B | +4.0% |
| Jun 30, 2025 | $11.1B | +7.4% |
| Sep 30, 2025 | $11.4B | +6.9% |
Revenue performance
Reported revenue rose from the previous quarter, extending a pattern of sequential gains seen throughout the year. The year-over-year comparison also showed an increase.
Quarterly comparison
Revenue improved compared with both the immediately preceding quarter and the same quarter one year earlier. The year-over-year gain was larger than the sequential change.
What to watch
The filing notes an increase in trade receivables and inventory, which contributed to higher working capital.